Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans

Volume: 59, Issue: 1, Pages: 450 - 460
Published: Jan 1, 2015
Abstract
In Candida albicans, the ERG11 gene encodes lanosterol demethylase, the target of the azole antifungals. Mutations in ERG11 that result in an amino acid substitution alter the abilities of the azoles to bind to and inhibit Erg11, resulting in resistance. Although ERG11 mutations have been observed in clinical isolates, the specific contributions of individual ERG11 mutations to azole resistance in C. albicans have not been widely explored. We...
Paper Details
Title
Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Published Date
Jan 1, 2015
Volume
59
Issue
1
Pages
450 - 460
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.